Low Back Pain-Pipeline Review, H1 2017

Low Back Pain-Pipeline Review, H1 2017


  • Products Id :- GMDHC9227IDB
  • |
  • Pages: 96
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Low Back Pain-Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain-Pipeline Review, H1 2017, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.

Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Low Back Pain-Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Low Back Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 6, 9, 2, 1 and 6 respectively.

Low Back Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Low Back Pain (Central Nervous System).

The pipeline guide reviews pipeline therapeutics for Low Back Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Low Back Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Low Back Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Low Back Pain (Central Nervous System)

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Low Back Pain (Central Nervous System).

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Low Back Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Low Back Pain-Overview

Low Back Pain-Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Low Back Pain-Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Low Back Pain-Companies Involved in Therapeutics Development

Ache Laboratorios Farmaceuticos SA

Adynxx Inc

AnGes MG Inc

Array BioPharma Inc

Axsome Therapeutics Inc

Boehringer Ingelheim GmbH

Egalet Corp

Frontier Biotechnologies Co Ltd

Gador SA

Grunenthal GmbH

Hisamitsu Pharmaceutical Co Inc

Huons Co Ltd

Immune Pharmaceuticals Inc

KPI Therapeutics Inc

MD Biosciences GmbH

Mesoblast Ltd

Nektar Therapeutics

Orion Oyj

Pacira Pharmaceuticals Inc

Pfizer Inc

Regeneron Pharmaceuticals Inc

Stayble Therapeutics AB

Sun Pharma Advanced Research Company Ltd

Low Back Pain-Drug Profiles

(acetaminophen + caffeine + diclofenac sodium + orphenadrine)-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(acetaminophen + tramadol hydrochloride) + eperisone-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(clonidine hydrochloride + naltrexone hydrochloride)-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

(loxoprofen + methocarbamol)-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AB-001-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AMG-0101-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ARRY-954-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AYX-2-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

bupivacaine-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

cebranopadol-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

dexmedetomidine hydrochloride-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

fasinumab-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

HP-3150-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IG-8801-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

lidocaine hydrochloride-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MD-22-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

MPC-06ID-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

NKTR-181-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

oxycodone hydrochloride ER-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

SPARC-1401-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

STA-363-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

tanezumab-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

U-2902-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

zoledronic acid-Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Low Back Pain-Dormant Projects

Low Back Pain-Discontinued Products

Low Back Pain-Product Development Milestones

Featured News & Press Releases

Mar 24, 2017: AnGes: Investigational New Drug (IND) Application Submitted to the FDA

Mar 20, 2017: NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain

Mar 15, 2017: Durable Three-Year Outcomes In Degenerative Disc Disease After a Single Injection of Mesoblast's Cell Therapy

Aug 01, 2016: MesoblastS Full 24-Month Trial Results for Chronic Low Back Pain Presented at Spine Intervention Society Annual Meeting, Receive Award for Best Basic Science

Jul 25, 2016: Hisamitsu Pharmaceutical Announces the results of Phase II clinical study of HP-3150 in Japan for "Lower back pain" (an analgesic transdermal drug containing NSAIDs)

Jun 22, 2016: Frontier Biotech Reports Primary Endpoint Met in Phase 2 Trial of AB001 In Chronic Low Back Pain

Feb 29, 2016: Cebranopadol Top-Line Data From Phase IIb Trial in Chronic Lower Back Pain Demonstrate Clinically and Statistically Significant Improvements in Pain Across All Arms

Aug 28, 2015: Hisamitsu Pharmaceutical Announces commencement of the Phase II clinical study of HP-3150 in Japan for "Lower back pain" (an analgesic transdermal drug containing NSAIDs)

Feb 25, 2015: Nektar Announces Start of Phase 3 SUMMIT-07 Study of NKTR-181 in Patients with Chronic Low Back Pain

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Figures

Number of Products under Development for Low Back Pain, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products by Top 10 Targets, H1 2017

Number of Products by Stage and Top 10 Targets, H1 2017

Number of Products by Top 10 Mechanism of Actions, H1 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017

Number of Products by Top 10 Routes of Administration, H1 2017

Number of Products by Stage and Top 10 Routes of Administration, H1 2017

Number of Products by Molecule Types, H1 2017

Number of Products by Stage and Molecule Types, H1 2017

List of Tables

Number of Products under Development for Low Back Pain, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017

Products under Development by Companies, H1 2017

Products under Development by Companies, H1 2017 (Contd..1), H1 2017

Number of Products by Stage and Target, H1 2017

Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017

Number of Products by Stage and Route of Administration, H1 2017

Number of Products by Stage and Molecule Type, H1 2017

Low Back Pain-Pipeline by Ache Laboratorios Farmaceuticos SA, H1 2017

Low Back Pain-Pipeline by Adynxx Inc, H1 2017

Low Back Pain-Pipeline by AnGes MG Inc, H1 2017

Low Back Pain-Pipeline by Array BioPharma Inc, H1 2017

Low Back Pain-Pipeline by Axsome Therapeutics Inc, H1 2017

Low Back Pain-Pipeline by Boehringer Ingelheim GmbH, H1 2017

Low Back Pain-Pipeline by Egalet Corp, H1 2017

Low Back Pain-Pipeline by Frontier Biotechnologies Co Ltd, H1 2017

Low Back Pain-Pipeline by Gador SA, H1 2017

Low Back Pain-Pipeline by Grunenthal GmbH, H1 2017

Low Back Pain-Pipeline by Hisamitsu Pharmaceutical Co Inc, H1 2017

Low Back Pain-Pipeline by Huons Co Ltd, H1 2017

Low Back Pain-Pipeline by Immune Pharmaceuticals Inc, H1 2017

Low Back Pain-Pipeline by KPI Therapeutics Inc, H1 2017

Low Back Pain-Pipeline by MD Biosciences GmbH, H1 2017

Low Back Pain-Pipeline by Mesoblast Ltd, H1 2017

Low Back Pain-Pipeline by Nektar Therapeutics, H1 2017

Low Back Pain-Pipeline by Orion Oyj, H1 2017

Low Back Pain-Pipeline by Pacira Pharmaceuticals Inc, H1 2017

Low Back Pain-Pipeline by Pfizer Inc, H1 2017

Low Back Pain-Pipeline by Regeneron Pharmaceuticals Inc, H1 2017

Low Back Pain-Pipeline by Stayble Therapeutics AB, H1 2017

Low Back Pain-Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2017

Low Back Pain-Dormant Projects, H1 2017

Low Back Pain-Dormant Projects, H1 2017 (Contd..1), H1 2017

Low Back Pain-Discontinued Products, H1 2017

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ache Laboratorios Farmaceuticos SA, Adynxx Inc, AnGes MG Inc, Array BioPharma Inc, Axsome Therapeutics Inc, Boehringer Ingelheim GmbH, Egalet Corp, Frontier Biotechnologies Co Ltd, Gador SA, Grunenthal GmbH, Hisamitsu Pharmaceutical Co Inc, Huons Co Ltd, Immune Pharmaceuticals Inc, KPI Therapeutics Inc, MD Biosciences GmbH, Mesoblast Ltd, Nektar Therapeutics, Orion Oyj, Pacira Pharmaceuticals Inc, Pfizer Inc, Regeneron Pharmaceuticals Inc, Stayble Therapeutics AB, Sun Pharma Advanced Research Company Ltd

select a license

Single User License
USD 2000 INR 129120
Site License
USD 4000 INR 258240
Corporate User License
USD 6000 INR 387360

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com